Sinsin Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	83,134	88,899	82,376	94,664	84,651	97,850
Market Cap Growth	-11.04%	7.92%	-12.98%	11.83%	-13.49%	-29.43%
Enterprise Value	122,644	131,411	122,361	135,899	130,024	145,574
Last Close Price	5480.00	5860.00	5354.84	6085.51	5387.79	6171.41
PE Ratio	8.94	9.57	16.85	20.23	19.18	-
PS Ratio	0.73	0.78	0.77	0.92	0.92	1.32
PB Ratio	1.12	1.19	1.26	1.53	1.42	1.79
P/TBV Ratio	1.12	1.20	1.26	1.53	1.43	1.80
P/FCF Ratio	11.93	12.75	18.56	-	18.59	-
P/OCF Ratio	9.69	10.36	13.86	24.09	15.50	4220.66
EV/Sales Ratio	1.08	1.16	1.15	1.33	1.41	1.97
EV/EBITDA Ratio	8.21	8.80	10.97	13.67	14.16	62.51
EV/EBIT Ratio	11.37	12.18	17.76	22.64	23.96	-
EV/FCF Ratio	17.59	18.85	27.57	-	28.56	-
Debt / Equity Ratio	0.59	0.59	0.70	0.72	0.73	0.84
Debt / EBITDA Ratio	2.92	2.92	4.09	4.48	4.73	19.85
Debt / FCF Ratio	6.27	6.27	10.27	-	9.55	-
Net Debt / Equity Ratio	0.53	0.53	0.69	0.71	0.69	0.83
Net Debt / EBITDA Ratio	2.67	2.67	4.04	4.44	4.49	19.51
Net Debt / FCF Ratio	5.71	5.71	10.15	-40.84	9.06	-17.09
Asset Turnover	0.85	0.85	0.84	0.84	0.78	0.64
Inventory Turnover	3.87	3.87	4.34	4.60	4.98	4.60
Quick Ratio	0.64	0.64	0.56	0.59	0.71	0.76
Current Ratio	0.98	0.98	0.87	0.91	1.06	1.08
Return on Equity (ROE)	13.25%	13.25%	7.54%	7.64%	7.62%	-2.61%
Return on Assets (ROA)	5.05%	5.05%	3.39%	3.06%	2.88%	-0.72%
Return on Invested Capital (ROIC)	8.95%	9.08%	5.95%	5.80%	5.40%	-1.35%
Return on Capital Employed (ROCE)	14.00%	14.00%	9.80%	8.30%	6.90%	-1.70%
Earnings Yield	11.18%	10.45%	5.93%	4.94%	5.21%	-1.51%
FCF Yield	8.39%	7.84%	5.39%	-1.14%	5.38%	-2.72%
Payout Ratio	9.80%	9.80%	18.62%	16.21%	-	-
Buyback Yield / Dilution	0.15%	0.15%	-0.07%	-	-	-
Total Shareholder Return	1.23%	0.15%	-0.07%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.